Login to Your Account

Cancer genomics firm Inivata pulls in $42M in series A funding

By Nuala Moran
Staff Writer

Tuesday, January 26, 2016

LONDON – Inivata Ltd. has raised £31.5 million (US$42.2 million) in a series A round, to advance the commercialization of its circulating tumor DNA liquid biopsy technology.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription